Although the relative increase in HbA 1c target attainment did not reach statistical significance, the absolute risk difference of 4.7% corresponds to a number needed to treat of approximately 21, suggesting a modest but potentially clinically relevant absolute benefit at the population level.
← all excerpts
Long-Term Mobile-Based Glycemic Intervention for Secondary Prevention in Patients With Diabetes Undergoing Surgical Revascularization: Multicenter Randomized Controlled Trial.
1
—
—